Resolved conflicts between phylogenetic groupings and existing taxonomic nomenclature to improve classification accuracy of genetic sequences in the order of bacteria known as Clostridiales.
Worked on a method that utilizes comparative genomics to help predict functional relationships between genes in Mycobacterium tuberculosis and related organisms.
Utilized HDACi to induce expression of drug metabolizing enzyme genes in liver cell lines with the goal of creating a more efficient and cost-effective human liver model for drug toxicity screening.
Found evidence to suggest that microtubule inhibitors have effects on cancer cells beyond simply inhibiting structural elements; in fact, these commonly used chemotherapy drugs seemed to alter aspects of energy metabolism.